MedGenyx, PLLC

12/08/2025

04/25/2025

01/09/2025

Pharmacogenomics (PGx) is focused on the relationship between an individual's genetic makeup and their response to medications, with the overarching aim of guiding prescribing decisions to improve drug efficacy and reduce adverse events. The PGx and genomic medicine communities have worked independe...

07/24/2024

MedGenyx NEW Blog Post! -

How Can Pharmacogenomics Improve Medication Management?

07/20/2024

Support Pharmacogenetic Consultations Delivered By Qualified Clinical Pharmacists.

07/11/2024

06/21/2024

https://medcitynews.com/2024/06/from-reactive-to-proactive-how-precision-medicine-transforms-the-break-and-fix-healthcare-system/

Reacting to an adverse medical event after it has progressed to causing the patient to seek medical help is the least opportune time to address the underlying disease.

06/20/2024

The evidence to date supports CYP2C19 genetic testing before oral P2Y12 inhibitors are prescribed in patients with acute coronary syndromes or percutaneous coronary intervention.

There is significant variability in the efficacy and safety of oral P2Y12 inhibitors, which are used to prevent ischemic outcomes in common diseases such as coronary and peripheral arterial disease and stroke. Clopidogrel, a prodrug, is the most used oral P2Y12 inhibitor and is activated primarily a...

06/17/2024

Unlock the power of pharmacogenomics with MedGenyx!

05/09/2024

Deprescribing in older adults with polypharmacy.